Letrozole
Anovulation
GABRIEL MONTEIRO PINHEIROSmall moleculePhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 66/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Anovulation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CLOMIPHENE CITRATE Xiyuan Hospital of China Academy of Chinese Medical Sciences | Phase 4 | BBB |
Metformin Ain Shams Maternity Hospital | Phase 4 | BBB |
Folate University Magna Graecia | Phase 4 | BB |
Hcg Assiut University | Phase 3 | BB |
Recombinant Human Follicle Stimulating Hormone University of California, San Diego | Phase 4 | BB |
View all 15 →
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →